ArticleCancers2024

Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials.

Lucia Masarova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.